Market Cap 20.55B
Revenue (ttm) 2.07B
Net Income (ttm) 418.30M
EPS (ttm) N/A
PE Ratio 79.92
Forward PE 66.78
Profit Margin 20.19%
Debt to Equity Ratio 1.27
Volume 191,021
Avg Vol 866,112
Day's Range N/A - N/A
Shares Out 70.38M
Stochastic %K 6%
Beta 1.35
Analysts Strong Sell
Price Target $341.05

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 600 7000
Address:
100 Nagog Park, Acton, United States
Estimize
Estimize Jul. 14 at 1:01 PM
Wall St is expecting 0.92 EPS for $PODD Q2 [Reporting 08/07 AMC] http://www.estimize.com/intro/podd?chart=historical&metric_name=eps&utm_co
0 · Reply
CelestialIronMan
CelestialIronMan Jul. 13 at 10:21 AM
$DXCM $LLY $NVO $PODD $SANA I say again, you might want to look at SANA
0 · Reply
JInvestTrade
JInvestTrade Jul. 8 at 9:02 PM
$SENS this was posted on LinkedIn recently. Bringing awareness to $SENS eversense 365 CGM. $DXCM, $ABOTT, $TNDM, $PODD https://www.linkedin.com/posts/arizona-adces_azadces-diabetescare-eversense365-activity-7348431742283730948--dRO?utm_source=share&utm_medium=member_ios&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM
0 · Reply
Estimize
Estimize Jul. 8 at 1:01 PM
Wall St is expecting 0.92 EPS for $PODD Q2 [Reporting 08/07 AMC] http://www.estimize.com/intro/podd?chart=historical&metric_name=eps&utm_co
0 · Reply
AdrianDittmann
AdrianDittmann Jul. 7 at 6:00 PM
$TNDM $PODD $MDT that is 20% more revenue from diabetics https://scitechdaily.com/new-anti-aging-gene-therapy-extends-lifespan-by-up-to-20/
0 · Reply
Estimize
Estimize Jul. 7 at 1:00 PM
Wall St is expecting 0.92 EPS for $PODD Q2 [Reporting 08/07 AMC] http://www.estimize.com/intro/podd?chart=historical&metric_name=eps&utm_co
0 · Reply
TraderRapp
TraderRapp Jul. 5 at 4:33 AM
$TNDM $PODD is 10x valued than Tandem. I realize the two company fundamentals are different however to be ten-fold different?
1 · Reply
1986iamwallstreet
1986iamwallstreet Jul. 1 at 3:43 PM
$PODD below 280 in play ….
0 · Reply
wystwyg
wystwyg Jun. 30 at 10:27 PM
$PODD Anyone know what’s happening AH?
1 · Reply
AdrianDittmann
AdrianDittmann Jun. 24 at 5:29 PM
$SANA $TNDM $PODD $MDT $SPY Have you seen Sana Biotech's new treatment, they were able to transfer modified islet cells that can evade the immune system. I think we are finally there! What do you guys think?
4 · Reply
Latest News on PODD
Outlier Money Flows Lift Insulet

May 14, 2025, 7:20 AM EDT - 2 months ago

Outlier Money Flows Lift Insulet


Insulet Announces Publication of 2024 Sustainability Report

May 13, 2025, 6:00 AM EDT - 2 months ago

Insulet Announces Publication of 2024 Sustainability Report


Insulet Is the Top S&P 500 Performer Today. Here's Why.

May 9, 2025, 10:11 AM EDT - 2 months ago

Insulet Is the Top S&P 500 Performer Today. Here's Why.


Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:35 PM EDT - 2 months ago

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript


Insulet beats quarterly profit estimates on insulin pump demand

May 8, 2025, 4:28 PM EDT - 2 months ago

Insulet beats quarterly profit estimates on insulin pump demand


Insulet Names New CEO, Expects to Top Revenue Projections

Apr 28, 2025, 10:26 AM EDT - 2 months ago

Insulet Names New CEO, Expects to Top Revenue Projections


Insulet Appoints Ashley McEvoy President and CEO

Apr 28, 2025, 6:00 AM EDT - 2 months ago

Insulet Appoints Ashley McEvoy President and CEO


Insulet Announces Pricing of Senior Notes Due 2033

Mar 18, 2025, 4:32 PM EDT - 4 months ago

Insulet Announces Pricing of Senior Notes Due 2033


Insulet Announces Proposed Financing Transactions

Mar 18, 2025, 7:35 AM EDT - 4 months ago

Insulet Announces Proposed Financing Transactions


Insulet Leans Bullish (Technical Analysis)

Mar 17, 2025, 11:53 PM EDT - 4 months ago

Insulet Leans Bullish (Technical Analysis)


Insulet to Host Investor Day on June 5, 2025

Mar 11, 2025, 6:00 AM EDT - 4 months ago

Insulet to Host Investor Day on June 5, 2025


Insulet Sales Keep Rising

Feb 26, 2025, 8:04 AM EST - 5 months ago

Insulet Sales Keep Rising


Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 11:37 PM EST - 5 months ago

Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript


Heavy Interest in Insulet's Insulin Delivery Device

Dec 27, 2024, 3:47 PM EST - 7 months ago

Heavy Interest in Insulet's Insulin Delivery Device


Insulet to Present at Upcoming Investor Conferences

Nov 15, 2024, 6:00 AM EST - 8 months ago

Insulet to Present at Upcoming Investor Conferences


Insulet CEO on earnings, GLP-1 and election impact

Nov 11, 2024, 4:59 PM EST - 8 months ago

Insulet CEO on earnings, GLP-1 and election impact


Buy, Sell, Or Hold Insulet (PODD) Stock?

Nov 11, 2024, 9:42 AM EST - 8 months ago

Buy, Sell, Or Hold Insulet (PODD) Stock?


Top 4 Health Care Stocks That May Plunge This Quarter

Nov 11, 2024, 6:18 AM EST - 8 months ago

Top 4 Health Care Stocks That May Plunge This Quarter

AIRS NUVB QDEL


Insulet Corporation (PODD) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 10:54 PM EST - 8 months ago

Insulet Corporation (PODD) Q3 2024 Earnings Call Transcript


Upstart, Insulet And 2 Other Stocks Executives Are Selling

Sep 12, 2024, 7:44 AM EDT - 10 months ago

Upstart, Insulet And 2 Other Stocks Executives Are Selling

UPST INTU Z


What Helped Insulet Stock Gain 10% This Week?

Aug 30, 2024, 9:00 AM EDT - 11 months ago

What Helped Insulet Stock Gain 10% This Week?


This Healthcare Stock Is the Best Performer in the S&P 500 Tuesday

Aug 27, 2024, 11:32 AM EDT - 11 months ago

This Healthcare Stock Is the Best Performer in the S&P 500 Tuesday


Estimize
Estimize Jul. 14 at 1:01 PM
Wall St is expecting 0.92 EPS for $PODD Q2 [Reporting 08/07 AMC] http://www.estimize.com/intro/podd?chart=historical&metric_name=eps&utm_co
0 · Reply
CelestialIronMan
CelestialIronMan Jul. 13 at 10:21 AM
$DXCM $LLY $NVO $PODD $SANA I say again, you might want to look at SANA
0 · Reply
JInvestTrade
JInvestTrade Jul. 8 at 9:02 PM
$SENS this was posted on LinkedIn recently. Bringing awareness to $SENS eversense 365 CGM. $DXCM, $ABOTT, $TNDM, $PODD https://www.linkedin.com/posts/arizona-adces_azadces-diabetescare-eversense365-activity-7348431742283730948--dRO?utm_source=share&utm_medium=member_ios&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM
0 · Reply
Estimize
Estimize Jul. 8 at 1:01 PM
Wall St is expecting 0.92 EPS for $PODD Q2 [Reporting 08/07 AMC] http://www.estimize.com/intro/podd?chart=historical&metric_name=eps&utm_co
0 · Reply
AdrianDittmann
AdrianDittmann Jul. 7 at 6:00 PM
$TNDM $PODD $MDT that is 20% more revenue from diabetics https://scitechdaily.com/new-anti-aging-gene-therapy-extends-lifespan-by-up-to-20/
0 · Reply
Estimize
Estimize Jul. 7 at 1:00 PM
Wall St is expecting 0.92 EPS for $PODD Q2 [Reporting 08/07 AMC] http://www.estimize.com/intro/podd?chart=historical&metric_name=eps&utm_co
0 · Reply
TraderRapp
TraderRapp Jul. 5 at 4:33 AM
$TNDM $PODD is 10x valued than Tandem. I realize the two company fundamentals are different however to be ten-fold different?
1 · Reply
1986iamwallstreet
1986iamwallstreet Jul. 1 at 3:43 PM
$PODD below 280 in play ….
0 · Reply
wystwyg
wystwyg Jun. 30 at 10:27 PM
$PODD Anyone know what’s happening AH?
1 · Reply
AdrianDittmann
AdrianDittmann Jun. 24 at 5:29 PM
$SANA $TNDM $PODD $MDT $SPY Have you seen Sana Biotech's new treatment, they were able to transfer modified islet cells that can evade the immune system. I think we are finally there! What do you guys think?
4 · Reply
AdrianDittmann
AdrianDittmann Jun. 24 at 2:18 AM
$SANA $TNDM $PODD $MDT $SPY okay do the liver next, so I can drink more https://www.globenewswire.com/news-release/2025/06/23/3103540/0/en/sana-biotechnology-announces-positive-six-month-clinical-results-from-type-1-diabetes-study-of-islet-cell-transplantation-without-immunosuppression.html
1 · Reply
Estimize
Estimize Jun. 23 at 1:03 PM
Wall St is expecting 0.92 EPS for $PODD Q2 [Reporting 08/07 AMC] http://www.estimize.com/intro/podd?chart=historical&metric_name=eps&utm_co
0 · Reply
CelestialIronMan
CelestialIronMan Jun. 19 at 5:39 PM
$SANA There is no way $LLY $NVO $DXCM $PODD are going to allow us to disrupt T1D treatments out of existence without participation. Once again ask your favorite AI what the HIP platform can be applied too! If we have to actually throw the possibilities of cures out in the public domain to force big pharma to partner and license so be it. But there is no way the company can make it through clinical trials to approval in its current form for anything. Go look up the process, typically 1000 patients over years, with some exceptions for gene therapies, rare diseases, the number of beneficiaries and efficacy can speed it up. We’d be bankrupt, bought off the scrap heap. Better to offer HIP, a working MSCB and targeted delivery tech, all of which we have or are developing than to actually make cures and incur the wrath of the big pharma machinery!
1 · Reply
IN0V8
IN0V8 Jun. 16 at 8:45 PM
$PODD Buy Truist Securities initiates coverage with buy rating Truist Securities initiates coverage with price target $365
0 · Reply
JarvisFlow
JarvisFlow Jun. 16 at 4:08 PM
Truist Securities has adjusted their stance on Insulet ( $PODD ), setting the rating to Buy with a target price of 365.
0 · Reply
zoey1970
zoey1970 Jun. 13 at 3:23 PM
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 3:41 PM
$PODD has risen 55.5% over the past year — is Insulet's growth sustainable? 🚀 Omnipod 5's expansion is a game changer, driving strong adoption with new customer starts, especially in the Type 2 diabetes market. However, macroeconomic challenges and fierce competition could cloud future growth prospects. Opportunity assessment here 👉 https://www.zacks.com/commentary/2494363/heres-why-you-should-retain-podd-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2494363-body&ADID=SYND_STOCKTWITS_TWEET_2_2494363_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 1:44 PM
$PODD gaining steam — here's why it deserves a spot in your portfolio 📈 Omnipod 5 is seeing strong momentum from global expansion and growing adoption among Type 2 users, even with economic and competitive pressures in play. Full breakdown here 👉 https://www.zacks.com/stock/news/2494363/heres-why-you-should-retain-podd-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2494363-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2494363_TEASER
0 · Reply
CelestialIronMan
CelestialIronMan Jun. 9 at 2:34 PM
$SANA I hate cross posting, but I’d love feedback on SANA from you guys over in $DXCM $PODD Nobody wants to hear about threats to their stocks but in this case you all should start looking at SANA. I talk a lot of shit, get in a lot of spats, have a lot of attempts to be funny, I shit on shorts! Every once in a while I help shepherd people to AMD back in 2017, NVTS, BCRX, HOOD, BITCOIN,PLTR through various accounts through the years. I think SANA is another winner, not here for followers or subscriptions. Check it out and comment we need more educated eyes over on our SANA thread here! The science is real https://wsw.com/webcast/jeff319/sana/1837256?mobile=True Wall Street Webcasting - Sana Biotechnology Commentary https://www.zerohedge.com/news/2025-05-19/end-diabetes-industry The End Of The T1 Diabetes Industry? | ZeroHedge
1 · Reply
trowley0001
trowley0001 Jun. 6 at 12:27 AM
$PODD nah. Keep shorting
1 · Reply
1trendingup
1trendingup Jun. 2 at 6:14 PM
$BBNX lol been loading since low 10’s. Watch out $PODD we’re coming for you
0 · Reply
topstockalerts
topstockalerts May. 30 at 4:26 PM
$PODD let it consolidate.. 😴😴
0 · Reply